Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Briggs A, Sculpher M, Claxton K (2006) Decision modelling for health economic evaluation. Oxford University Press, Oxford
2. Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD, Force I-SMGRPT (2012) Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6. Value Health 15(6):835–842. https://doi.org/10.1016/j.jval.2012.04.014
3. Canadian Agency for Drugs and Technologies in Health (2017) Guidelines for the economic evaluation of health technologies: Canada. Ottawa (ON): The Agency. https://www.cadth.ca/sites/default/files/pdf/guidelines_for_the_economic_evaluation_of_health_technologies_canada_4th_ed.pdf. Accessed 10 Nov 2022.
4. Degeling K, IJzerman MJ, Koopman M, Koffijberg H (2017) Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models. BMC Med Res Methodol 17(1):170. https://doi.org/10.1186/s12874-017-0437-y
5. Di Tanna GL, Porter JK, Lipton RB, Hatswell AJ, Sapra S, Villa G (2019) Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials. Health Qual Life Outcomes 17(1):171. https://doi.org/10.1186/s12955-019-1242-6